Video wird geladen...
Video konnte nicht geladen werden
Many physicians may have historically overlooked the lymphocyte count, largely because, prior to the FDA approval of Anktiva in June 2025, there were none (as told by my mothers oncologist at UCLA) options to meaningfully increase a patient’s lymphocyte count. The recent availability of Anktiva marks a significant advancement,... show more
45,170 Aufrufe • vor 1 Jahr •via X (Twitter)
0 Kommentare
Keine Kommentare verfügbar
Kommentare vom Original-Post werden hier angezeigt
